Frequently Asked Questions



International Forum of Allergy & Rhinology

Frequently Asked Questions About the New AAOA-ARS Journal

Q: Why did ARS and AAOA decide to change their official journals from established, indexed journals with reasonable impact factors for a new journal launch?
  1. There are several reasons; here are some of the most important:
    1. Economic:
      1. For the ARS, financial losses reportedly incurred by the publisher of AJRA resulted in a reduction in journal pages for scientific content, creating an unacceptable delay in getting papers published.
      2. The same financial losses have led to increased subscription fees and increasing strain on on ARS’ resources.
      3. For AAOA, the relationship with Otolaryngology/Head and Neck Surgery was relatively unstructured, and AAOA received no financial compensation for its sponsorship of the journal.
      4. The AAOA and ARS jointly own the new journal, and will own the copyright of all articles published therein, as well as sharing equitably with the publisher, Wiley-Blackwell, in the revenues of the journal.
    2. Intellectual Property:
      1. The American Rhinologic Society does not own its most important resource: the academic content of material published in AJRA; nor does the AAOA own the content from Otolaryngology/Head and Neck Surgery.  Association best practices indicate that, unless there is an extraordinarily favorable agreement with a publisher who owns an affiliated journal, it is strategically advisable for societies to own the intellectual property that they generate and the journals in which the IP is published.
    3. Relationship:
      1. Our new journal Allergy & Rhinology provides a unique opportunity for the two major subsocieties in otolaryngology/head and neck surgery focusing on allergy and rhinology -- the AAOA and the ARS -- to combine their resources and efforts to develop the premiere journal dealing with these topics, while forging important relationships for future collaborations.
 

 
Q: When will Allergy& Rhinology be indexed, and have an impact factor?

Startup journals can apply for MEDLINE indexing after 4 issues.  This would be within one year.  Of greatest importance, as long as the journal is indexed within 4 years of the first issue, all content back to volume 1 issue 1 will be indexed in MEDLINE. The impact factor will be calculated at about 2-3 years.


 


Q:
What can I do as a member, researcher, clinician?

Use the journal as you normally would!  Read Allergy & Rhinology, submit your papers to it, cite articles published in it.  Volunteer as a reviewer! Talk about the new journal to your colleagues and students! Sign up to receive an email alert telling you when new articles or issues are published!

The indexing and impact of a journal are simply a measure of the journal’s usefulness and importance.  This journal will cross into the specialties of sinonasal allergic disease, sinusitis, skull base tumors, medical and surgical rhinology.  With your help, Allergy & Rhinology has the potential to be a pre-eminent international journal of our disciplines.




Q: When will Allergy & Rhinology launch?

The first issue will be published in print and online in January or February 2011, but papers will appear online (fully citable) during 2010.  Wiley-Blackwell is working on establishing a submission site for papers, to go live shortly after the Editor is appointed, and we will keep you informed about when and how to submit your papers.



Q: How will the Editor be selected?

The Journal’s Steering Committee has sent out an announcement about the Editor position to all members of both organizations, with information about how to apply or nominate a colleague, and applications are due in mid-January.  Selected candidates will be interviewed by the Committee and a decision made shortly thereafter.


Visit the journal website.





Revised 02/25/2014
©American Rhinologic Society